Antibody-Mediated Serum Resistance Protects Pseudomonas aeruginosa During Bloodstream Infections.

Sarah M Hickson Johannes K HoehensteigerJohanna Mayer-CoverdaleVon Vergel L TorresWenkang FengJoshua N MonteithIan R HendersonKate L McCarthyTimothy J Wells

Published in: The Journal of infectious diseases (2024)

cAbs are prevalent in patients with P aeruginosa BSI and allow survival of otherwise serum-sensitive bacteria in the bloodstream. Generation of cAbs may be a risk factor for the development of BSI.

Keyphrases

pseudomonas aeruginosa
cystic fibrosis
biofilm formation
escherichia coli
drug resistant